"People who say this will be a quick turnaround are really overoptimistic, " says Eric Bosshard of Midwest Research, who has been covering the company for ten years.
Dr Georg Bosshard, from the University of Zurich, told the committee that although no doctor really wanted to assist someone to end their life, it was "sometimes the lesser of two evils".